It’s called Ocula, and it’s the pharmaceutical breakthrough of the 21st century. No longer are patients bound by unreliable sleeping medications that only treat the symptoms of insomnia and sleeplessness.
With Ocula, patients are treated at the source of their insomnia, freeing them to experience the perfect eight-hour sleep cycle—guaranteed.
How is this possible? Because Ocula is the first drug in the history of pharmacology to use gene-silencing technology—also known as antisense therapy—to inhibit the genes responsible for chronic sleep disorders.
By binding to your body’s RNA, and then blocking the production of faulty proteins, Ocula keeps the genes linked to insomnia and sleeplessness from reproducing.
The result? A genetic sequence that defaults to the human body’s natural eight-hour sleep cycle.
Say goodbye to tossing and turning through sleepless nights . . . relying on addictive sleeping pills that leave you feeling groggy and tired the next day . . . worrying about trudging through another day at work without sleep.
Isn’t it time you got the quality shut-eye you deserve?
Well now you can. So if you can’t sleep, don’t worry—Asteria Pharmaceuticals has a pill for that.
Ocula: Rest Easy with Us
Be sure to check out J.M. Lanham’s pharmaceutical/sci-fi thriller, The R.E.M. Effect, available now on Amazon.com.